Bio-Rad Laboratories Pre-Tax Profit Margin 2010-2023 | BIO.B
Current and historical pre-tax profit margin for Bio-Rad Laboratories (BIO.B) from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Bio-Rad Laboratories pre-tax profit margin for the three months ending March 31, 2023 was .
| Bio-Rad Laboratories Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2023-03-31 |
$2.78B |
$-0.25B |
-9.03% |
| 2022-12-31 |
$2.80B |
$-4.70B |
-167.88% |
| 2022-09-30 |
$2.81B |
$-7.83B |
-279.04% |
| 2022-06-30 |
$2.87B |
$-2.60B |
-90.42% |
| 2022-03-31 |
$2.90B |
$-0.22B |
-7.46% |
| 2021-12-31 |
$2.92B |
$5.45B |
186.42% |
| 2021-09-30 |
$2.98B |
$8.57B |
287.42% |
| 2021-06-30 |
$2.88B |
$5.23B |
181.49% |
| 2021-03-31 |
$2.70B |
$5.32B |
196.82% |
| 2020-12-31 |
$2.55B |
$4.92B |
193.17% |
| 2020-09-30 |
$2.38B |
$4.53B |
190.25% |
| 2020-06-30 |
$2.29B |
$2.51B |
109.37% |
| 2020-03-31 |
$2.33B |
$2.03B |
87.25% |
| 2019-12-31 |
$2.31B |
$2.26B |
97.79% |
| 2019-09-30 |
$2.31B |
$0.52B |
22.60% |
| 2019-06-30 |
$2.29B |
$1.21B |
52.69% |
| 2019-03-31 |
$2.29B |
$0.78B |
33.86% |
| 2018-12-31 |
$2.29B |
$0.51B |
22.40% |
| 2018-09-30 |
$2.29B |
$1.60B |
69.75% |
| 2018-06-30 |
$2.28B |
$1.28B |
56.11% |
| 2018-03-31 |
$2.21B |
$0.94B |
42.59% |
| 2017-12-31 |
$2.16B |
$0.10B |
4.54% |
| 2017-09-30 |
$2.11B |
$0.02B |
1.14% |
| 2017-06-30 |
$2.09B |
$0.02B |
0.77% |
| 2017-03-31 |
$2.10B |
$0.04B |
2.00% |
| 2016-12-31 |
$2.07B |
$0.04B |
2.03% |
| 2016-09-30 |
$2.07B |
$0.12B |
6.00% |
| 2016-06-30 |
$2.03B |
$0.13B |
6.21% |
| 2016-03-31 |
$2.02B |
$0.14B |
6.89% |
| 2015-12-31 |
$2.02B |
$0.15B |
7.23% |
| 2015-09-30 |
$2.05B |
$0.14B |
6.74% |
| 2015-06-30 |
$2.11B |
$0.14B |
6.40% |
| 2015-03-31 |
$2.14B |
$0.14B |
6.73% |
| 2014-12-31 |
$2.18B |
$0.13B |
6.07% |
| 2014-09-30 |
$2.18B |
$0.13B |
6.01% |
| 2014-06-30 |
$2.15B |
$0.10B |
4.83% |
| 2014-03-31 |
$2.14B |
$0.10B |
4.86% |
| 2013-12-31 |
$2.13B |
$0.11B |
5.30% |
| 2013-09-30 |
$2.10B |
$0.13B |
6.23% |
| 2013-06-30 |
$2.10B |
$0.19B |
9.10% |
| 2013-03-31 |
$2.08B |
$0.21B |
9.99% |
| 2012-12-31 |
$2.07B |
$0.23B |
11.12% |
| 2012-09-30 |
$2.05B |
$0.25B |
12.27% |
| 2012-06-30 |
$2.06B |
$0.25B |
12.22% |
| 2012-03-31 |
$2.08B |
$0.24B |
11.76% |
| 2011-12-31 |
$2.07B |
$0.25B |
11.86% |
| 2011-09-30 |
$2.06B |
$0.22B |
10.64% |
| 2011-06-30 |
$2.01B |
$0.22B |
10.98% |
| 2011-03-31 |
$1.96B |
$0.22B |
11.13% |
| 2010-12-31 |
$1.93B |
$0.22B |
11.41% |
| 2010-09-30 |
$1.89B |
$0.21B |
10.85% |
| 2010-06-30 |
$1.88B |
$0.20B |
10.54% |
| 2010-03-31 |
$1.84B |
$0.19B |
10.45% |
| 2009-12-31 |
$1.78B |
$0.19B |
10.37% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.988B |
$2.802B |
|
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
|
